Solstice director Ward Pat granted 2 RSUs

Solstice Advanced Materials Inc. (symbol: SOLS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Filing Summary

Solstice Advanced Materials Inc. (symbol: SOLS) is the issuer of record for a Form 4 filing submitted to the SEC. Ward Pat reported acquisition or exercise transactions in this Form 4 filing.

Solstice Advanced Materials Inc. (SOLS) reported that director Ward Pat received a grant of 2 restricted stock units (RSUs) on September 10, 2026, representing dividend equivalent rights that accrue in RSUs and cost no cash outlay. Each RSU represents a contingent right to receive one share of Solstice common stock and will vest on the earliest of the first anniversary of the grant date or the next annual meeting of shareowners. Following this grant, Ward holds 1,893 RSUs and 1,785 shares of common stock directly, and additional common shares are held in three irrevocable trusts for Diane, Caitlin, and Daniel Ward, where he serves as trustee and disclaims beneficial ownership except for any pecuniary interest.

Insider Trade Summary

Grant/Award: 2 shares

Grant/Award 5 txns

Insider Ward Pat

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F4, F5, F6	2	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock F1	--	--	--
holding	Common Stock F2	--	--	--
holding	Common Stock F3	--	--	--

Holdings After Transaction: Restricted Stock Units — 1,893 contracts (Direct); Common Stock — 1,785 shares (Direct); Common Stock — 24 shares (Indirect, By Trust)

Footnotes (6)

1. F1. These securities are held by the Diane Ward Irrevocable Trust, of which Mr. Ward serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
2. F2. These securities are held by the Caitlin Ward Irrevocable Trust, of which Mr. Ward serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
3. F3. These securities are held by the Daniel Ward Irrevocable Trust, of which Mr. Ward serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
4. F4. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number.
5. F5. Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same time as the underlying RSUs.
6. F6. The RSUs will vest on the earliest of the first anniversary of the grant date and the next annual meeting of shareowners of the Issuer.

Key Figures

RSUs granted: 2 RSUs RSUs held after grant: 1,893 RSUs Common stock held directly: 1,785 shares +2 more

5 metrics

RSUs granted 2 RSUs Dividend equivalent RSU grant to director Ward Pat on September 10, 2026

RSUs held after grant 1,893 RSUs Total direct restricted stock units held by Ward Pat after the transaction

Common stock held directly 1,785 shares Direct holdings of Solstice Advanced Materials Inc. common stock by Ward Pat

Derivative transactions reported 1 transaction Number of derivative-type transactions (RSU grant) in this Form 4

Holding entries reported 4 entries Common stock holding lines, including direct and trust-held positions

Key Terms

Restricted Stock Units, dividend equivalent rights, irrevocable trust, pecuniary interest

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

irrevocable trust financial

"These securities are held by the Diane Ward Irrevocable Trust"

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

pecuniary interest financial

"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SOLS director Ward Pat report on September 10, 2026?

He reported an acquisition of 2 restricted stock units (RSUs) on September 10, 2026. These RSUs are dividend equivalent rights that convert into Solstice Advanced Materials Inc. common stock upon vesting, with no cash price per unit disclosed.

How many RSUs does SOLS director Ward Pat hold after this Form 4 transaction?

After the September 10, 2026 grant, Ward Pat holds 1,893 restricted stock units directly. Each RSU represents a contingent right to receive one share of Solstice Advanced Materials Inc. common stock, subject to vesting conditions.

What are the vesting terms for the new RSUs reported by SOLS director Ward Pat?

The 2 RSUs vest on the earliest of the first anniversary of the grant date and the next annual meeting of shareowners of Solstice Advanced Materials Inc., aligning the award with the company’s annual governance cycle.

How many shares of SOLS common stock does Ward Pat hold directly after this filing?

He holds 1,785 shares of Solstice Advanced Materials Inc. common stock directly after the reported transaction. This figure is separate from his 1,893 RSUs, which are contingent rights to receive additional shares upon vesting.

Are any of the SOLS shares associated with Ward Pat held through trusts?

Yes. Additional Solstice common shares are held by the Diane, Caitlin, and Daniel Ward Irrevocable Trusts, for which he is trustee. He disclaims beneficial ownership of those trust-held securities except to the extent of his pecuniary interest in them.

Was the SOLS Form 4 transaction made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not selected, so there is no Rule 10b5-1 trading plan reported in connection with the September 10, 2026 RSU grant to director Ward Pat.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 05:38 PM Accepted by SEC EDGAR 09/14/2026 - 05:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ward Pat

(Last) (First) (Middle)

C/O SOLSTICE ADVANCED MATERIALS INC.

115 TABOR ROAD

(Street)

MORRIS PLAINS NEW JERSEY 07950

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Solstice Advanced Materials Inc. [ SOLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								1,785	D
Common Stock								6	I	By Trust(1)
Common Stock								9	I	By Trust(2)
Common Stock								9	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(4)	09/10/2026		A(5)		2		(6)	(6)	Common Stock	2	$0	1,893	D

Explanation of Responses:

1. These securities are held by the Diane Ward Irrevocable Trust, of which Mr. Ward serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

2. These securities are held by the Caitlin Ward Irrevocable Trust, of which Mr. Ward serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

3. These securities are held by the Daniel Ward Irrevocable Trust, of which Mr. Ward serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

4. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number.

5. Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same time as the underlying RSUs.

6. The RSUs will vest on the earliest of the first anniversary of the grant date and the next annual meeting of shareowners of the Issuer.

Remarks:

	/s/ Jay Shah for Pat Ward	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)